Cara Haymaker

[Linghua Wang, MD, PhD @IamLinghua]

Deeply grateful to Peggy and Carl Sewell for their visionary $10M gift and their trust in our mission. With this transformative support, we are building a new scientific frontier at @UTMDAnderson to decode the "language" of cancer. https://t.co/Z7THMXadc1

[Edgar Gonzalez-Kozlova @EdgarEGK]

Pancreatic neuroendocrine neoplasm is an aggressive rare cancer. Low-dose ipilimumab plus nivolumab demonstrated an 11% ORR in patients with refractory PNEN, with durable
benefit (>2 years) in 3 (16%) patients. https://t.co/7Xui3UuMAL in this study we aim to understand the why.

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort https://t.co/NhXZWI0fye
@youngkwangchae @anup_kasi @walshauserMD @EdgarEGK @Dra_Cells @EladSharonMD @cara_haymaker @Dr_R_Kurzrock

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC short report: Intratumoral neutrophil-to-lymphocyte ratio is mirrored by circulating neutrophil-to-lymphocyte ratio in non-small cell lung cancer https://t.co/Syhs85MDKD @mvnegrao @LaurenByersMD @AReubenPhD @maraantonoff @sgswisher @cara_haymaker @MDAndersonNews

[Society for Immunotherapy of Cancer @sitcancer]

SITC is deeply concerned by the announcement from NIH that will cut billions of dollars in indirect costs. We urge the NIH & the new administration to reverse this action to ensure life-saving cancer treatments continue to reach the clinic and patients. https://t.co/eqLJOoBDIP

[UT MD Anderson @UTMDAnderson]

During the CATALYST summer program, MD Anderson gives aspiring scientists the opportunity to train with world-renowned faculty in a state-of-the-art research facility at the nation's top cancer hospital.

Register here by Jan. 15: https://t.co/RtZEj2CtC1

[Diane Bodurka @DianeBodurka]

Applications for our @MDAndersonNews 2025 CATALYST Summer Training Program are open! This is an excellent opportunity for high school, undergraduate, graduate and medical students to gain exposure to cancer research. More information: https://t.co/wAoJUY9GMg @kandymarsy @swatowic

[UT MD Anderson @UTMDAnderson]

Research led by our postdoctoral fellow Dr. Marina Medina Rosales focused on defining the phenotypic states of circulating myeloid cells in patients with oligometastatic cancer (Abstract 891). @ChadTangMD @Cara_Haymaker @SITCancer #SITC24 #EndCancer

[UT MD Anderson @UTMDAnderson]

Our Dr. Jacqueline Oliva, a postdoctoral fellow working with Dr. @Cara_Haymaker shared a functional and transcriptomic evaluation of pleural mesothelioma tumor expanded infiltrating lymphocytes (Abstract 456). @Liszeth @SITCancer #SITC24 #EndCancer

[UT MD Anderson @UTMDAnderson]

Featuring work done with our Drs. Luisa Solis Soto and @Cara_Haymaker, our Dr. Ayse Koksoy presented a novel algorithm to identify lymphoid structures in the tumor microenvironment (Abstract 205). @SITCancer #SITC24 #EndCancer

[Cara Haymaker @cara_haymaker]

@MDAndersonNews @KatTomcat1 @sitcancer Amazing presentation showcasing our mesothelioma research efforts!

[UT MD Anderson @UTMDAnderson]

Our Dr. Katarzyna Tomczak shared results at #SITC24 from multi-omic profiling of the tumor immune microenvironment in patients with pleural mesothelioma.
Learn more (Abstract 1413): https://t.co/Sxb1NyAQzg @KatTomcat1 @SITCancer #EndCancer

[Carin Hagberg, MD @CarinHagberg]

Mentoring is essential to navigate challenges, expand leadership roles, and fuel career growth. Faculty Academic Career Development @MDAndersonNews supports mentorship for faculty to reach their full potential. An excellent panel of mentors! #EndCancer @EGrubbsMD @AnneTsao2

[UT MD Anderson @UTMDAnderson]

Today, students from the CATALYST Summer Training Program presented their research projects. From the 16 programs, more than 230 posters were presented and eight awards were given. #Research #SummerTraining #STEMEducation #MDAnderson #EndCancer

[Society for Immunotherapy of Cancer @sitcancer]

Be part of the future of immuno-oncology at #SITC24! Network & explore innovations from researchers from around the world. Nov. 6–10, 2024 | Houston, TX or Virtual. Early registration ends next week Aug. 14. Save $200! https://t.co/vsEADfyMse #ImmunoOncology #EndCancer

[Anirban Maitra @Aiims1742]

I registered for @sitcancer annual meeting in Houston!
Come share some 🌮 with us in town & enjoy the best of immuno-oncology.

[Foundation for the National Institutes of Health @FNIH_Org]

As we close out Cancer Immunotherapy Month, we are proud to share this new video which examines the Partnership for Accelerating Cancer Therapies (PACT). The video highlights the crucial collaborations between The National Institutes of Health, FDA, academia, patient organizations, and the private sector, including the integral Cancer Immune Monitoring and Analysis Centers and the Cancer Immunologic Data Center (CIMAC-CIDC) Network.

PACT, one of the flagship public-private partnerships managed by FNIH, aims to maximize the benefits of immunotherapies for all cancer patients. Part of the Cancer Moonshot Research Initiatives, PACT is studying samples from 37 clinical trials representing 4,000 participants and 15+ types of cancer, to better understand when patients do or don’t respond to immunotherapy.

Learn more about PACT: https://t.co/16Omq6aTCP

#CancerImmunotherapyMonth #PACT #CancerMoonshot #Immunotherapy #CancerResearch #cancer

@theNCI @abbvie @Amgen @Boehringer @boehringerus @bmsnews @US_FDA @genenetech @GileadSciences @GSK @GSKUS @JanssenUS @Novartis @NovartisCancer @NovartisScience @NovartisMedical @pfizer @pfizer_news @sanofi @SanofiUS @danafarber @DanaFarberNews @MDAndersonNews @Stanford @StanfordMed @IcahnMountSinai

[Foundation for the National Institutes of Health @FNIH_Org]

June is Cancer Immunotherapy Month. The Partnership for Accelerating Cancer Therapies (PACT), one of the flagship public-private partnerships managed by FNIH, aims to maximize the benefits of immunotherapies for all cancer patients. Part of the Cancer Moonshot Research Initiatives, PACT is studying samples from 37 clinical trials representing 4,000 participants and 15+ types of cancer, to better understand when patients do or don’t respond to immunotherapy.

We are proud to share this teaser video for a full video premiering next week, which will examine the partnership’s impact in the field of immunotherapy. The video will also highlight the crucial collaborations between @NIH, @FDA, academia, and the private sector, including the integral Cancer Immune Monitoring and Analysis Centers and the Cancer Immunologic Data Center (CIMAC-CIDC) Network.

Learn more about PACT: https://t.co/16Omq6aTCP

#CancerImmunotherapyMonth #PACT #CancerMoonshot #Immunotherapy #CancerResearch #cancer #BridgesToBreakthroughs

@thenci @abbvie @Amgen @Boehringer @bmsnews @genentech @GSK @GSKUS @GileadSciences @JanssenUS @Novartis @pfizer @pfizer_news @sanofi @SanofiUS @DanaFarber @DanaFarberNews @MDAndersonNews @Stanford @StanfordMed @AccoiOrg

[Carin Hagberg, MD @CarinHagberg]

☀️ The CATALYST program offers access to summer cancer research programs across @MDAndersonNews. An incredible opportunity to enhance research and clinical skills. Prepare for an enriching journey into the world of healthcare and science! #EndCancer @DianeBodurka

[Diane Bodurka @DianeBodurka]

Looking forward to the May @MDAndersonNews Grand Rounds presentation by Faculty Educator of the Quarter, VP, and Chief Data Officer @ca_chung on “Institute for Data Science in Oncology and Our Data Ecosystem.” Join us at 11 a.m. on May 16.@paolophd @shilpa_surasi @cara_haymaker